TNF-Ó y su receptor soluble en LES: implicaciones clínicas

Bezanilla L., María Antonieta; Guzmán Meléndez, María Antonieta; Agar Muñoz, Ana María.
Reumatología (Santiago de Chile) ; 11(1): 28-30, 1995. ilus, tab
Artículo en Español | LILACS | ID: lil-153027

Documentos relacionados

  1. Structural modeling of tumor necrosis factor: A protein of immunological importance.
  2. Group 3 innate lymphoid cells produce the growth factor HB-EGF to protect the intestine from TNF-mediated inflammation.
  3. Innate Lymphocyte/Ly6C(hi) Monocyte Crosstalk Promotes Klebsiella Pneumoniae Clearance.
  4. The Role of IgG Fc Region N-Glycosylation in the Pathomechanism of Rheumatoid Arthritis.
  5. Tumor Necrosis Factor Alpha-Induced Interleukin-1 Alpha Synthesis and Cell Death Is Increased in Mouse Epithelial Cells Infected With Chlamydia muridarum.
  6. Customizable Multiplex Antibody Array Immunoassays with Attomolar Sensitivities.
  7. [Tumor necrosis factor alpha (TNF-α) in autoimmune diseases (AIDs): molecular biology and genetics].
  8. The role of interleukins and their inhibitors in the development of autoimmune uveitis.
  9. Tumor necrosis factor alpha in mycobacterial infection.
  10. Functional characterization of a putative lipopolysaccharide-induced TNF-alpha factor (LITAF) from blood clam Tegillarca granosa in innate immunity.